
Biojoint 50mg Tablet
Marketer
Elfin Pharma Pvt Ltd
Salt Composition
Diacerein (50mg)
Overview Biojoint 50mg Tablet
ArthriCare 50mg tablets effectively manage osteoarthritis symptoms. This medication reduces pain and inflammation, promoting faster joint recovery. It can be administered independently or alongside other treatments. ArthriCare 50mg should be taken with meals, consistently at the same time daily. Therapeutic effects may become apparent after several weeks. A regular exercise regimen, focusing on strengthening muscles surrounding affected joints and weight management, complements this medication. Discontinue use only after consulting your physician. Minor side effects, including altered bowel movements or urine color, may occur. Diabetic patients require close blood glucose monitoring, as ArthriCare may elevate blood sugar levels.
Primary Ingredients of Biojoint 50mg Tablet
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Biojoint 50mg Tablet
Degenerative joint disease
Major Benefits of Biojoint 50mg Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Biojoint 50mg Tablets should be administered with food.
Common Side effects of Biojoint 50mg Tablet:
- Diarrhea
- Urine discoloration
How to use Biojoint 50mg Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Biojoint 50mg Tablets should be administered with a meal.
How Biojoint 50mg Tablet works:
Biojoint 50mg tablets promote the regeneration of cartilage, a crucial component of joint structure. This effect is achieved by stimulating proteoglycan production, thus facilitating joint repair and mitigating associated pain and inflammation.
SAFETY ADVICE
AlcoholCAUTION
It's recommended to avoid alcohol while taking Biojoint 50mg Tablets. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Biojoint 50mg Tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Biojoint 50mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCONSULT YOUR DOCTOR
Biojoint 50mg Tablet's impact on driving ability is undetermined. Refrain from driving if you experience any symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
Biojoint 50mg tablets appear safe for use in individuals with kidney disease. Existing evidence indicates dose modification may not be necessary. However, physician consultation is recommended.
LiverCAUTION
Patients with advanced hepatic impairment should exercise caution when using Biojoint 50mg tablets, as dose modification may be necessary. Physician consultation is recommended.
What if you forget to take Biojoint 50mg Tablet :
Omit any missed Biojoint 50mg Tablet dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Biojoint 50mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Anthracene Carboxylic Acids |
| Developing Habits | No. |
| Treatment Category | Pain Relief Medications |
